The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Alekseeva L.I.
Nasonova Scientific Research Institute of Rheumatology;
Russian Medical Academy for Continuous Professional Education
Bakhtadze M.A.
Scientific Research Institute of General Pathology and Pathophysiology;
Pirogov Russian National Research Medical University
Davydov O.S.
Scientific Research Institute of General Pathology and Pathophysiology
Devlikamova F.I.
Kazan State Medical Academy — Branch of the Russian Medical Academy for Continuous Professional Education
Kukushkin M.L.
Scientific Research Institute of General Pathology and Pathophysiology
Churyukanov M.V.
Sechenov First Moscow State Medical University (Sechenov University);
Petrovsky Russian Scientific Center of Surgery
Disease-modifying therapy and adjuvant support in complex therapy of chronic non-specific low back pain. Resolution of the Multidisciplinary Board of Experts
Journal: Russian Journal of Pain. 2024;22(3): 108‑116
Views: 423
Downloaded: 24
To cite this article:
Alekseeva LI, Barulin AE, Bakhtadze MA, et al. . Disease-modifying therapy and adjuvant support in complex therapy of chronic non-specific low back pain. Resolution of the Multidisciplinary Board of Experts. Russian Journal of Pain.
2024;22(3):108‑116. (In Russ.)
https://doi.org/10.17116/pain202422031108
The objective of the multidisciplinary expert panel consensus was to determine the place and role of disease-modifying and adjuvant therapy for osteoarthritis of the facet joints in patients with nonspecific back pain. Key issues in the management of patients with chronic nonspecific back pain were updated, taking into account its epidemiology, new data about risk factors and molecular pathogenesis, modern international and Russian clinical recommendations and algorithms for the management of patients with low back pain, analysis of pharmacology and evidence-based data medicine about the effectiveness and safety of the use of disease-modifying osteoarthritis drugs (DMOADs) in these patients. The Council of Experts presents an optimized algorithm for managing these patients using courses of therapy with the parenteral form of the drug highly purified chondroitin sulfate Chondroguard (Pharmaceutical company «Sotex» CJSC, Russia), glucosamine sulfate (Sustagard Arthro and Sustagard, Pharmaceutical company «Sotex» CJSC, Russia), and also with the use of nutritional support of pharmaconutraceuticals «Chondroguard TRIO» (dietary supplement) and with combined nutraceuticals, including vitamins D3 (cholecalciferol) and K2 (menaquinone). The consensus resolution noted the need to discuss the inclusion of active DMOADs compounds and adjuvant therapy for osteoarthritis in clinical guidelines for the management of patients with chronic musculoskeletal low back pain for the purpose of its effective and safe control and prevention.
Keywords:
Authors:
Alekseeva L.I.
Nasonova Scientific Research Institute of Rheumatology;
Russian Medical Academy for Continuous Professional Education
Bakhtadze M.A.
Scientific Research Institute of General Pathology and Pathophysiology;
Pirogov Russian National Research Medical University
Davydov O.S.
Scientific Research Institute of General Pathology and Pathophysiology
Devlikamova F.I.
Kazan State Medical Academy — Branch of the Russian Medical Academy for Continuous Professional Education
Kukushkin M.L.
Scientific Research Institute of General Pathology and Pathophysiology
Churyukanov M.V.
Sechenov First Moscow State Medical University (Sechenov University);
Petrovsky Russian Scientific Center of Surgery
Received:
10.07.2024
Accepted:
15.07.2024
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.